Prohealth Limited, importers and distributors of leading Pharmaceutical and Dermo-Cosmetic brands since 1995, has strengthened its corporate governance in response to sustained growth and development registered in Malta and overseas. Peter Apap, co-founder and director of the company has been appointed Chief Executive Officer, effective 1st November.
The other co-founders and executive directors John Jaccarini and Andrew Paris have responsibility for export business development, and procurement and regulatory affairs respectively. Joseph FX Zahra, who has been a consultant with Prohealth for the last two years, chairs the board of directors in a non-executive capacity. The company also announced the appointment of Andrew Spiteri Willets as Financial Controller.
These changes are aimed at growing the company’s market share in Malta, by consolidation of its well-known brands such as La Roche-Posay, Vichy, Ursapharm and Kin, as well as the introduction of new products, and continued rapid growth of its more recently established Medical Devices Division. This restructuring will also enable Prohealth to embark on a more aggressive drive to develop further business in new export markets in addition to its established Libya market in the years to come.